Setting

Asia Pacific Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Country: Trend Outlook and Growth Opportunity

Published: 30 Jun 2021 | Report Code: 10248059 | Pages: 90

Asia Pacific diagnostic specialty antibodies market will grow by 7.0% annually with a total addressable market cap of $46.1 billion over 2021-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer. Highlighted with 27 tables and 37 figures, this 90-page report “Asia Pacific Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific diagnostic specialty antibodies market in every aspect of the classification from perspectives of Type, Application, End User, and Country. Based on Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Monoclonal Antibodies • Polyclonal Antibodies • Other Types Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Natural/Biological Products • Synthetic Products Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Oncology Diagnosis • Hepatitis Diagnosis • Infectious Disease Diagnosis • Dengue Diagnostics • Tuberculosis Diagnostics • HIV Diagnostics • Other Applications Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hospitals & Clinics • Diagnostic Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Type, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories Abcam plc Agilent Technologies, Inc. Aytu BioScience, Inc. Becton, Dickinson and Company Bio-Rad Laboratories, Inc. Boehringer Ingelheim International GmbH Creative Diagnostics Enzo Life Sciences, Inc. F. Hoffmann-La Roche AG Merck KGaA Polymun Scientific Immunbiologische Forschung GmbH Sanofi S.A. Sartorius AG Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	5
1.1 Industry Definition and Research Scope	5
1.1.1 Industry Definition	5
1.1.2 Research Scope	6
1.2 Research Methodology	9
1.2.1 Overview of Market Research Methodology	9
1.2.2 Market Assumption	10
1.2.3 Secondary Data	10
1.2.4 Primary Data	10
1.2.5 Data Filtration and Model Design	11
1.2.6 Market Size/Share Estimation	12
1.2.7 Research Limitations	13
1.3 Executive Summary	14
2 Market Overview and Dynamics	16
2.1 Market Size and Forecast	16
2.1.1 Impact of COVID-19 on World Economy	17
2.1.2 Impact of COVID-19 on the Market	19
2.2 Major Growth Drivers	21
2.3 Market Restraints and Challenges	24
2.4 Emerging Opportunities and Market Trends	27
2.5 Porter’s Fiver Forces Analysis	31
3 Segmentation of Asia Pacific Market by Type	35
3.1 Market Overview by Type	35
3.2 Monoclonal Antibodies	37
3.3 Polyclonal Antibodies	38
3.4 Other Types	39
4 Segmentation of Asia Pacific Market by Application	40
4.1 Market Overview by Application	40
4.2 Oncology Diagnosis	42
4.3 Hepatitis Diagnosis	43
4.4 Infectious Disease Diagnosis	44
4.5 Dengue Diagnostics	45
4.6 Tuberculosis Diagnostics	46
4.7 HIV Diagnostics	47
4.8 Other Applications	48
5 Segmentation of Asia Pacific Market by End User	49
5.1 Market Overview by End User	49
5.2 Hospitals & Clinics	51
5.3 Diagnostic Laboratories	52
5.4 Other End Users	53
6 Asia-Pacific Market 2020-2027 by Country	54
6.1 Overview of Asia-Pacific Market	54
6.2 China	57
6.3 Japan	59
6.4 India	62
6.5 Australia	64
6.6 South Korea	66
6.7 Rest of APAC Region	68
7 Competitive Landscape	70
7.1 Overview of Key Vendors	70
7.2 New Product Launch, Partnership, Investment, and M&A	73
7.3 Company Profiles	74
Abbott Laboratories	74
Abcam plc	76
Agilent Technologies, Inc.	77
Aytu BioScience, Inc.	78
Becton, Dickinson and Company	79
Bio-Rad Laboratories, Inc.	80
Boehringer Ingelheim International GmbH	81
Creative Diagnostics	82
Enzo Life Sciences, Inc.	83
F. Hoffmann-La Roche AG	84
Merck KGaA	85
Polymun Scientific Immunbiologische Forschung GmbH	86
Sanofi S.A.	87
Sartorius AG	88
Thermo Fisher Scientific Inc.	89
RELATED REPORTS	90
List Of Tables

Table 1.  Snapshot of Asia Pacific Diagnostic Specialty Antibodies Market in Balanced Perspective, 2020-2027	15
Table 2. Growth Rate of World GDP, 2020-2022	18
Table 3.  Main Product Trends and Market Opportunities in Asia Pacific Diagnostic Specialty Antibodies Market	27
Table 4. Asia Pacific Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	35
Table 5. Asia Pacific Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	40
Table 6. Asia Pacific Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	49
Table 7. APAC Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn	55
Table 8. China Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	58
Table 9. China Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	58
Table 10. China Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	58
Table 11. Japan Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	61
Table 12. Japan Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	61
Table 13. Japan Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	61
Table 14. India Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	63
Table 15. India Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	63
Table 16. India Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	63
Table 17. Australia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	65
Table 18. Australia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	65
Table 19. Australia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	65
Table 20. South Korea Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	67
Table 21. South Korea Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	67
Table 22. South Korea Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	67
Table 23. Diagnostic Specialty Antibodies Market in Rest of APAC by Country/Region, 2017-2027, $ mn	69
Table 24. Abbott Laboratories: Company Snapshot	74
Table 25. Abbott Laboratories: Business Segmentation	74
Table 26. Abbott Laboratories: Product Portfolio	75
Table 27. Abbott Laboratories: Revenue, 2017-2019, $ mn	75
List Of Figures

Figure 1. Research Method Flow Chart	9
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	12
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027	14
Figure 4. Asia Pacific Diagnostic Specialty Antibodies Market, 2017-2027, $ mn	16
Figure 5. Impact of COVID-19 on Business	19
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Diagnostic Specialty Antibodies Market	21
Figure 7. Primary Restraints and Impact Factors of Asia Pacific Diagnostic Specialty Antibodies Market	24
Figure 8. Investment Opportunity Analysis	28
Figure 9. Porter’s Fiver Forces Analysis of Asia Pacific Diagnostic Specialty Antibodies Market	31
Figure 10. Breakdown of Asia Pacific Diagnostic Specialty Antibodies Market by Type, 2020-2027, % of Revenue	35
Figure 11. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%)	36
Figure 12. Asia Pacific Diagnostic Specialty Antibodies Market: Monoclonal Antibodies, 2017-2027, $ mn	37
Figure 13. Asia Pacific Diagnostic Specialty Antibodies Market: Polyclonal Antibodies, 2017-2027, $ mn	38
Figure 14. Asia Pacific Diagnostic Specialty Antibodies Market: Other Types, 2017-2027, $ mn	39
Figure 15. Breakdown of Asia Pacific Diagnostic Specialty Antibodies Market by Application, 2020-2027, % of Revenue	40
Figure 16. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)	41
Figure 17. Asia Pacific Diagnostic Specialty Antibodies Market: Oncology Diagnosis, 2017-2027, $ mn	42
Figure 18. Asia Pacific Diagnostic Specialty Antibodies Market: Hepatitis Diagnosis, 2017-2027, $ mn	43
Figure 19. Asia Pacific Diagnostic Specialty Antibodies Market: Infectious Disease Diagnosis, 2017-2027, $ mn	44
Figure 20. Asia Pacific Diagnostic Specialty Antibodies Market: Dengue Diagnostics, 2017-2027, $ mn	45
Figure 21. Asia Pacific Diagnostic Specialty Antibodies Market: Tuberculosis Diagnostics, 2017-2027, $ mn	46
Figure 22. Asia Pacific Diagnostic Specialty Antibodies Market: HIV Diagnostics, 2017-2027, $ mn	47
Figure 23. Asia Pacific Diagnostic Specialty Antibodies Market: Other Applications, 2017-2027, $ mn	48
Figure 24. Breakdown of Asia Pacific Diagnostic Specialty Antibodies Market by End User, 2020-2027, % of Revenue	49
Figure 25. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by End User, Value ($ mn) and Share (%)	50
Figure 26. Asia Pacific Diagnostic Specialty Antibodies Market: Hospitals & Clinics, 2017-2027, $ mn	51
Figure 27. Asia Pacific Diagnostic Specialty Antibodies Market: Diagnostic Laboratories, 2017-2027, $ mn	52
Figure 28. Asia Pacific Diagnostic Specialty Antibodies Market: Other End Users, 2017-2027, $ mn	53
Figure 29. Breakdown of APAC Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue	55
Figure 30. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)	56
Figure 31.  Diagnostic Specialty Antibodies Market in China, 2017-2027, $ mn	57
Figure 32.  Diagnostic Specialty Antibodies Market in Japan, 2017-2027, $ mn	60
Figure 33.  Diagnostic Specialty Antibodies Market in India, 2017-2027, $ mn	62
Figure 34.  Diagnostic Specialty Antibodies Market in Australia, 2017-2027, $ mn	64
Figure 35.  Diagnostic Specialty Antibodies Market in South Korea, 2017-2027, $ mn	66
Figure 36.  Diagnostic Specialty Antibodies Market in Rest of APAC, 2017-2027, $ mn	68
Figure 37. Growth Stage of Asia Pacific Diagnostic Specialty Antibodies Industry over the Forecast Period	70
Key Players (this may not be a complete list and extra companies can be added upon request): 
Abbott Laboratories
Abcam plc
Agilent Technologies, Inc.
Aytu BioScience, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim International GmbH
Creative Diagnostics
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Polymun Scientific Immunbiologische Forschung GmbH
Sanofi S.A.
Sartorius AG
Thermo Fisher Scientific Inc.
 (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)